The expression and activity of NEP is significantly reduced in AD mice and patients, so maintaining and increasing the expression and activity of NEP is a potential strategy for the prevention and treatment of Aβ disease (Bourassa et al., 2019). This evidence concerns the gene MME and Alzheimer disease.